JOSHUA CABRERA: Open Payments
NPI 1235254483 · BRYAN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$351 in 18 payments from 8 companies in 2025. Trend: 2023 $336 · 2024 $385 · 2025 $351
Food & beverage: $351
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $72 |
| ABBVIE INC. | 4 | $58 |
| Janssen Pharmaceuticals, Inc | 2 | $56 |
| Alkermes, Inc. | 2 | $41 |
| Supernus Pharmaceuticals, Inc. | 2 | $38 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Indivior Inc. | 1 | $33 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
Products named: COBENFY, VRAYLAR, INVEGA SUSTENNA, Qelbree, ABILIFY ASIMTUFII, SUBLOCADE, LYBALVI, UZEDY.
Industry payments across TX — which companies pay providers there.
